SCDM EMEA Blog Post
[event_date_range] – [acf field="event_location"] – Booth [acf field="event_booth"]
Nonclinical Development Science Services Blog Post
Download PDF
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions Blog Post
2025 年 3 月 5 日 McKemey joins Certara to accelerate growth of its strategic drug development solutions RADNOR, PA – March 5th, 2025 – Certara, Inc. （纳斯达克股票代码：CERT), 作为全球... Certara Integral: The Master Data Repository Powering Efficient and Collaborative PK/PD Workflows Blog Post
[event_date_range]
Behind the Science: A Conversation with Katrina Hui Blog Post
You May Also Like AllVideo Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at CertaraBlending Science & Impact in Drug Development: Felix Boakye-Agyeman,...
Postmarketing Assessment of Antibody–Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index Approach Blog Post
Overview This study explores a model-based meta-analysis (MBMA) and a clinical utility index (CUI) approach to assess the benefit–risk profiles of antibody–drug conjugates (ADCs). The focus is on two approved...
Machine Learning for PK/PD Modeling in Drug Development Blog Post
定量药理学家可运用机器学习进行药代动力学/药效学（PK/PD）建模，以更高效评估在研药物的安全性及有效性。
